KEGG analysis revealed that these genes were enriched in tumor pathways closely related to tumor pathways, including EGFR tyrosine kinase inhibitor resistance, PI3K-Akt signaling pathway, PD-L1 expression, and PD-1 checkpoint pathway (Figure 1C). The gene discussed is CD274; the disease is neoplasm.